Evidence map›Paper›PMID 31123409›Full record

ArticleOncoTargets and therapy2019

Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS) promotes retinoblastoma progression via sponging miR-506-3p.

Ning Han, Ling Zuo, Han Chen, Chunxia Zhang, Pei He, Hongtao Yan

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Long non-coding RNAs involved in retinoblastoma.Journal of cancer research and clinical oncology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Checking NEKs: Overcoming a Bottleneck in Human Diseases.Molecules (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Article
  14. Non-Coding RNAs in Pediatric Solid Tumors.Frontiers in genetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ning HanDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Ling ZuoDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Han ChenDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Chunxia ZhangDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Pei HeDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Hongtao YanDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, People's Republic of China.
Second Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosisLncRNAmiR-506-3pproliferationretinoblastoma

Identifiers

PMID31123409
PMCPMC6511239
OpenAlexW2942960804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.